Zealand Stock Today

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>ZP</div>
Zealand Pharma is selling for 241.40 as of the 26th of May 2020. This is -1.47% down since the beginning of the trading day. The stock's open price was 245.0. Zealand Pharma has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 30 days. Equity ratings for Zealand Pharma AS are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 26th of February 2020 and ending today, the 26th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance0 100 

Zealand Pharma Profile

Zealand Pharma AS, a biotechnology company, engages in the discovery and development of peptide based medicines in Denmark. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 191 people. more on Zealand Pharma
Legal NameZealand Pharma AS
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Zealand Pharma AS (ZEAL) is traded on Copenhagen Stock Exchange in Denmark and employs 191 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 8.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zealand Pharma's market, we take the total number of it shares issued and multiply it by the Zealand Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Zealand Pharma AS operates under Healthcare sector and is part of Biotechnology industry. The entity has 35.99 M outstanding shares. ZEALAND PHARMA has accumulated about 1.54 B in cash with (390.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 43.11.
Check Zealand Pharma Probability Of Bankruptcy

Ownership Allocation (%)

Zealand Stock Price Odds Analysis

Odds Down 241.4HorizonTargetOdds Up 241.4
72.09%30 days
 241.40 
27.79%
Based on normal probability distribution, the odds of Zealand Pharma to move above current price in 30 days from now is about 27.79 (This Zealand Pharma AS probability density function shows the probability of Zealand Pharma Stock to fall within a particular range of prices over 30 days) .

Zealand Pharma Income Statement Over Time

Zealand Pharma AS Income Statement is one of the three primary financial statements used for reporting Zealand's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zealand Pharma AS revenue and expense. Zealand Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period. Direct Expenses is projected to rize to about 3.1 M this year View More Fundamentals

Zealand Stock Against Markets

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module
Check out Your Current Watchlist. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page